Thrombotic Thrombocytopenic Purpura: A Thrombotic Disorder Caused by ADAMTS13 Deficiency
- 31 August 2007
- journal article
- review article
- Published by Elsevier in Hematology/Oncology Clinics of North America
- Vol. 21 (4) , 609-632
- https://doi.org/10.1016/j.hoc.2007.06.003
Abstract
No abstract availableKeywords
This publication has 105 references indexed in Scilit:
- Comparison and stability of ADAMTS13 activity in therapeutic plasma productsTransfusion, 2006
- Exosite interactions contribute to tension-induced cleavage of von Willebrand factor by the antithrombotic ADAMTS13 metalloproteaseProceedings of the National Academy of Sciences, 2006
- Activation-independent platelet adhesion and aggregation under elevated shear stressBlood, 2006
- Inhibitory autoantibodies against ADAMTS-13 in patients with thrombotic thrombocytopenic purpura bind ADAMTS-13 protease and may accelerate its clearance in vivoJournal of Thrombosis and Haemostasis, 2006
- Measurement of von Willebrand factor cleaving protease (ADAMTS‐13): results of an international collaborative study involving 11 methods testing the same set of coded plasmasJournal of Thrombosis and Haemostasis, 2004
- von Willebrand factor cleaving protease (ADAMTS13) is deficient in recurrent and familial thrombotic thrombocytopenic purpura and hemolytic uremic syndromeBlood, 2002
- von Willebrand factor-cleaving protease activity in congenital thrombotic thrombocytopenic purpuraBritish Journal of Haematology, 2000
- Thrombotic Thrombocytopenic Purpura Associated with ClopidogrelNew England Journal of Medicine, 2000
- Angiotropic large cell lymphoma presenting as thrombotic microangiopathy (thrombotic thrombocytopenic purpura)Cancer, 1995
- Congenital Deficiency of a Factor in Normal Plasma That Reverses Microangiopathic Hemolysis and ThrombocytopeniaNew England Journal of Medicine, 1978